DRIO Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
5.2M
-7.3%
5.6M
+6.7%
5.2M
+4.5%
5.0M
-6.7%
5.4M
Cost of Revenue
2.0M
-16.7%
2.4M
-1.8%
2.4M
+21.8%
2.0M
-17.2%
2.4M
Gross Profit
3.2M
-0.3%
3.2M
+14.1%
2.8M
-7.0%
3.0M
+1.7%
3.0M
Operating Expenses
9.7M
-8.0%
10.5M
-7.5%
11.4M
-9.1%
12.5M
+2.8%
12.2M
R&D
2.1M
-11.9%
2.4M
-9.5%
2.6M
-20.9%
3.3M
-10.6%
3.7M
SG&A
7.6M
-6.8%
8.1M
-7.0%
8.7M
-4.8%
9.2M
+8.6%
8.4M
Operating Income
-6479000
+11.4%
-7309000
+14.6%
-8562000
+9.7%
-9484000
-3.1%
-9200000
EBITDA
-5964000
+12.1%
-6785000
+15.5%
-8028000
+10.2%
-8938000
-6.4%
-8398000
Net Income
-7924000
+3.9%
-8249000
+8.7%
-9031000
+13.7%
-10466000
+19.4%
-12990000
EPS (Basic)
$-0.85
-168.0%
$1.25
$-2.96
+16.4%
$-3.54
EPS (Diluted)
$-0.85
-168.0%
$1.25
$-2.96
+16.4%
$-3.54
Shares (Diluted)
9.3M
-99.9%
6.6B
3.1M
+26.5%
2.5M
DarioHealth (DRIO) — Financials